PRIMA Lab SA Quality

DISCOVER QUALITY

Quality Management System

PRIMA Lab SA is committed to developing and manufacturing high quality, reliable products and services in the field of in vitro diagnostics for both self-testing and professional use in the human and veterinary fields.

PRIMA Lab SA Quality Management System is compliant with ISO 9001:2015 and EN ISO 13485:2016 requirements. All these certificates have been issued by mdc (Medical Device Certification).

ISO 9001:2015: This standard is based on a number of quality management principles including a strong customer focus, the motivation and implication of top management, the process approach and continual improvement.It can be used by any organization, large or small, regardless of its field of activity.
ISO 13485:2016: This international standard specifies the requirements for the Quality Management System in place in the organizations involved in the manufacture of medical devices and related services that meet customer and regulatory requirements.

Quality Policy

Offering innovative services and products in order to meet the expectations and requirements of customers in compliance with mandatory regulations, using a chain of qualified and experienced suppliers.
Adoption of the Quality Management System as main company tool in business management and in the management of continuous improvement, as a point of reference for the management of the company and its customers.
The compliance of products and services with applicable laws and technical standards is a priority for the company, which is also taken into account in marketing actions as a factor of competitive advantage on the market.
Preserving the following values: “Passion, Cooperation, Quality” which form the foundations of the Company’s culture and are key areas of focus across all functions of the business.

How PRIMA is facing the EU IVDR Regulation?

The new In Vitro Diagnostic Medical Device Regulation (IVDR) came into force on May 25, 2017 and was applied on May 26, 2022. We implemented quality procedures to comply with the EU IVDR requirements (e.g., Vigilance, Post-Market Surveillance requirements, PRRC) that are in force from the IVDR application.

PRIMA Lab SA’s Quality and Regulatory departments are committed to giving our customers and partners the best support in this transition. In the light of the recent implementation of the Reg. EU 2017/746 (IVDR) and given the importance and strategic impact of this Regulation on our business, we would like to share some key points about the PRIMA Lab SA transition plan to IVDR 2017/746:

  • PRIMA Lab SA has obtained an extension of the validity of the current CE certificate under IVDD 98/79/EC to guarantee an extended transition period for marketability purposes. The CE certificate # D1408400052 (IVDD 98/79/EC) issued by mdc is still applicable to PRIMA Lab SA rapid tests for self-testing and is valid until May 2025. PRIMA Lab SA rapid tests intended for professional use may continue to be marketed as foresee by provisions of Regulation 2022/112 depending on the risk class of each device.
  • PRIMA Lab SA has successfully implemented its quality system to comply with applicable IVDR requirements.
  • PRIMA Lab SA, as Swiss manufacturer, appointed an EU authorized representative to comply with requirements of Economic Operators highlighted in the IVDR
  • PRIMA Lab SA will maintain the current Notified Body mdc for the CE marking process. mdc 0483 has now been designated for IVDR and notified on NANDO as a Notified Body for IVDR services on Feb 16, 2023.
  • The IVD devices will be gradually CE marked according to IVDR based on a transition plan agreed with the Notified Body.

Our mission is to give you the best support to face the regulatory challenges emerged in the market!